Butterfly Network, Inc. · NYSE:BFLY

Butterfly Network — Investor Presentation (March 2021)

24 slides from Butterfly Network's investor presentation, Mar 5, 2021

  1. Slide 1: Butterfly: The New Image of Health – Corporate Presentation

    Sé Butterfly” The New Image of Health Corporate Presentation March 5, 2021

  2. Slide 2: Forward-Looking Statements

    Forward - Looking Statements This presentation includes "forward - looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Butterfly Network, Inc.’s (the “Company”) actual results may differ from its expectations,

  3. Slide 3: Management team and agenda

    `Æ”€õ Ɖ ØƋZј€·˜ÔØ Dr. Todd Fruchterman , M.D. , Ph.D President & Chief Executive Officer Dr. Jonathan M . Rothberg, Ph.D Founder & Chairman of the Board Dr. John Martin, M.D. Chief Medical Officer Gioel Molinari oSūƋ ¨ª˜¢ƋSÔÆ”äŽßƋHăŽ˜Ô Stephanie Fielding Chief Financial Officer Vision Overview Tech

  4. Slide 4: Company history and capital raised

    7 C - Corps (4 Catalyzer) >$750M raised TODAY Dr. Jonathan Rothberg invents next - gen DNA sequencing & wins Presidential Medal of Tech & Innovation 4 4Catalyzer and Butterfly Network are founded 2011 - 2020 2000 - 2011 Ôªî˜ÀƋõƋߨ˜ƋoªØªÆÀƋÆ¢Ƌ€ÀƋ.ÀÀÆî€ĉî˜Ƌ&ÆäÀ”˜Ô ÔŰƋ7ÆÀ€ß¨€ÀƋVÆß¨˜Ô£ƋS¨ ūƋ&ÆäÀ”˜ÔƋ€À

  5. Slide 5: Our Mission is to Democratize Medical Imaging

    of diagnostic dilemmas can be addressed through simple imaging 2 Our Mission is to Democratize Medical Imaging Improving healthcare access and delivery is critical. 5 of the world has no access to medical imaging 1 1. Per World Health Organization applied to current world population 2. https:// www.

  6. Slide 6: Overview

    Overview

  7. Slide 7: Innovation, Transformation, Impact

    Confidential — Not for Distribution äĊ˜ÔĈõƋZ߯Ôõ INNOVATION TRANSFORMATION IMPACT Highly differentiated proprietary hardware and software ultrasound technology that provides important diagnostic information at the point of care. By integrating the Butterfly solution into clinical workflow across a v

  8. Slide 8: Technology

    Technology

  9. Slide 9: 9

    9

  10. Slide 10: Connected Solution: A Disruptive Fusion of Hardware and Software

    © 2020 Butterfly Network, Inc. Connected Solution A Disruptive Fusion of Hardware and Software Sold in over 20 countries with FDA clearance and CE - Mark. Powered by Ultrasound - on - Chip lj 10 Clinical Data (GX &RQWHQW

  11. Slide 11: Semiconductor-Based Technology Designed to Reinvent Ultrasound

    Semiconductor - Based Technology Designed to Reinvent Ultrasound Semiconductors revolutionized the consumer imaging market twenty years ago and we expect it will revolutionize medical imaging for the coming decades. 1. See “How Many Photos Will Be Taken in 2020?” (January 10, 2020), https://focus.my

  12. Slide 12: Semiconductor-based Ultrasound Introduces a New Era of Imaging

    Semiconductor - based Ultrasound Introduces a New Era of Imaging Ultrasound - on - Chip lj is a proprietary, patented technological breakthrough. Traditional Handheld Butterfly # of probes for whole - body imaging 2 - 3 probe 1 probe Typical one - probe performance 1 - 4MHz 7 - 10MHz 1 - 10MHz Typica

  13. Slide 13: A Complete Imaging Ecosystem with Butterfly

    A Complete Imaging Ecosystem with Butterfly An all - in - one proprietary ultrasound solution to transform care delivery with over 200 patents issued .

  14. Slide 14: Clinical

    Clinical

  15. Slide 15: Butterfly is Working to Realize the Full Potential of POCUS

    Butterfly is Working to Realize the Full Potential of POCUS Breaking through the barriers of conventional ultrasound systems. Ultrasound usage today has been constrained by high upfront system cost, limited access, and suboptimal convenience. 15 Versatility SÆÔ߀ª¹ªċ Affordability eØ€ª¹ªċ

  16. Slide 16: Evolution of POCUS in Emergency Medicine

    16 16 Evolution of POCUS in Emergency Medicine The growth of EMED acts as a model for other specialties.

  17. Slide 17: Better Decisions Lead to Value Creation

    Better Decisions Lead to Value Creation Research released regularly to support value across healthcare system. 17 ;äÀ£Ƌä¹ßÔ€ØÆäÀ”Ƌ¢ÆÔƋߨ˜Ƌ”ª€£ÀÆØªØƋ Æ¢ƋZ VZ ƀ Æo ƀ ĐƋ SÀ˜ä¿ÆÀª€ƋªÀƋߨ˜Ƌ ¿˜Ô£˜ÀŽõƋ ˜Ñ€Ôß¿˜Àß A randomized controlled trial of lung ultrasound - guided therapy in heart failure eؘƋ€À”Ƌª¿Ñ€

  18. Slide 18: The Potential of POCUS with Butterfly

    The Potential of POCUS with Butterfly Disrupting the $8 billion global ultrasound market by expanding access to care in new care settings. Imaging Centers ,ÆØÑªß€¹ Niche Doctor Offices &äßäÔ˜Ƌ ôÑ€ÀتÆÀƋ Æ¢Ƌ €Ô˜Ƌ Z˜ĊªÀ£Ø Pre - Hospital Home Veterinary Dialysis Centers ASCs eÔ£˜ÀßƋ €Ô˜ Long - term Car

  19. Slide 19: Financials

    Financials

  20. Slide 20: Disrupting a Large and Expanding Total Addressable Market

    Disrupting a Large and Expanding Total Addressable Market Focus on expansion into new settings beyond legacy ultrasound market with large addressable populations. Sources: 1. Per WHO World Health Report Global Medical Doctors 2. Comprised of Anesthesiologists, Primary Care Physicians, Medical School

  21. Slide 21: Attractive Economic Characteristics to Drive Growth

    Confidential — Not for Distribution Attractive Economic Characteristics to Drive Growth , ;`,vƋ&.B B . ;Z FOCUSED INVESTMENT Z`VHB'Ƌ Z,ƋSHZ.`.HB Significant and sustainable revenue growth with improving gross margins. Focused near - term investments to build scale and drive growth. A strong balance

  22. Slide 22: Robust Revenue Growth with Roadmap to Compelling Margin

    Robust Revenue Growth with Roadmap to Compelling Margin Buying patterns will tend to weigh revenue toward Q4. ĐĐ 2020 Ǝ Ē ē 2021 Revenue ($ in millions) $78 2022 $137 ĐĎĐđ $235 ĐĎĐĒ $334 >70% 2020 2021 2022 ĐĎĐđ 2024 'ÔÆØØ Ƌ A€Ô£ªÀ 43% 51% 60% 68% N/A

  23. Slide 23: Strategy of Rapid Growth Through Investment in the Business

    ZßԀߘ£õƋÆ¢Ƌ V€Ñª”Ƌ'ÔÆïߨƋß¨ÔÆä£¨Ƌ.Àî˜Øß¿˜ÀßƋªÀƋߨ˜Ƌ äØªÀ˜ØØ B˜Ċ˜”ƋƎ ēĒĎ AAƋ¢ÔÆ¿ƋZS Ƌ€À”ƋS.S ƋªÀî˜Øß¿˜ÀߨƋ߯Ƌ¢˜˜”Ƌ£ÔÆïß¨Ű 23 Æ¿¿˜ÔŽª€¹ªú€ĉÆÀ Innovation Organizational Capabilities Rapidly scale go - to - market approach to reach and engage customers. Accelerate product development across clinical so

  24. Slide 24: Thank you

    }¢ Butterfly” Thank you

Butterfly Network — Investor Presentation (March 2021) on 6ix